Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes

  • Vargas Soria, María
  • Ramos Rodríguez, Juan José|||0000-0001-9081-5366
Background: While aging is the main risk factor for Alzheimer´s disease (AD), emerging evidence suggests that metabolic alterations such as type 2 diabetes (T2D) are also major contributors. Indeed, several studies have described a close relationship between AD and T2D with clinical evidence showing that both diseases coexist. A hallmark pathological event in AD is amyloid-β (Aβ) deposition in the brain as either amyloid plaques or around leptomeningeal and cortical arterioles, thus constituting cerebral amyloid angiopathy (CAA). CAA is observed in 85–95% of autopsy cases with AD and it contributes to AD pathology by limiting perivascular drainage of Aβ. Methods: To further explore these alterations when AD and T2D coexist, we have used in vivo multiphoton microscopy to analyze over time the Aβ deposition in the form of plaques and CAA in a relevant model of AD (APPswe/ PS1dE9) combined with T2D (db/db). We have simultaneously assessed the effects of high-fat diet-induced prediabetes in AD mice. Since both plaques and CAA are implicated in oxidative-stress mediated vascular damage in the brain, as well as in the activation of matrix metalloproteinases (MMP), we have also analyzed oxidative stress by Amplex Red oxidation, MMP activity by DQ ™ Gelatin, and vascular functionality. Results: We found that prediabetes accelerates amyloid plaque and CAA deposition, suggesting that initial metabolic alterations may directly affect AD pathology. T2D significantly affects vascular pathology and CAA deposition, which is increased in AD-T2D mice, suggesting that T2D favors vascular accumulation of Aβ. Moreover, T2D synergistically contributes to increase CAA mediated oxidative stress and MMP activation, affecting red blood cell velocity. Conclusions: Our data support the cross-talk between metabolic disease and Aβ deposition that affects vascular integrity, ultimately contributing to AD pathology and related functional changes in the brain microvasculature., University of Cadiz Predoctoral Fellowship, European Commission, European Commission Joint Research Centre GA 847749, Programa Estatal de Generacion de Conocimiento y Fortalecimiento Cientifico y Tecnologico del Sistema de I + D + i y del Programa Estatal de I + D +i Orientada a los Retos de la Sociedad, del Plan Estatal de Investigacion Cientifica y Tecnica y de Innovaci PID2020-115499RB-I00/AEI, Agencia Estatal de Investigacion (AEI) BFU 2016-75038-R, European Commission, Spanish Government Spanish Government, Andalucia se mueve con Europa P20-00928
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Regulatory T cells limit age-associated retinal inflammation and neurodegeneration

  • Llorián-Salvador, Maria
  • Fuente, Alerie G. de la
  • McMurran, Christopher E.
  • Dashwood, Amy
  • Dooley, James
  • Liston, Adrian
  • Penalva, Rosana
  • Dombrowski, Yvonne
  • Stitt, Alan W.
  • Fitzgerald, Denise C.
[Background] Ageing is the principal risk factor for retinal degenerative diseases, which are the commonest cause of blindness in the developed countries. These conditions include age-related macular degeneration or diabetic retinopathy. Regulatory T cells play a vital role in immunoregulation of the nervous system by limiting inflammation and tissue damage in health and disease. Because the retina was long-considered an immunoprivileged site, the precise contribution of regulatory T cells in retinal homeostasis and in age-related retinal diseases remains unknown., [Methods] Regulatory T cells were selectively depleted in both young (2–4 months) and aged (18–23 months) FoxP3-DTR mice. We evaluated neuroretinal degeneration, gliosis, subretinal space phagocyte infiltration, and retinal pigmented epithelium morphology through immunofluorescence analysis. Subsequently, aged Treg depleted animals underwent adoptive transfer of both young and aged regulatory T cells from wild-type mice, and the resulting impact on neurodegeneration was assessed. Statistical analyses employed included the U-Mann Whitney test, and for comparisons involving more than two groups, 1-way ANOVA analysis followed by Bonferroni’s post hoc test., [Results] Our study shows that regulatory T cell elimination leads to retinal pigment epithelium cell dysmorphology and accumulation of phagocytes in the subretinal space of young and aged mice. However, only aged mice experience retinal neurodegeneration and gliosis. Surprisingly, adoptive transfer of young but not aged regulatory T cells reverse these changes., [Conclusion] Our findings demonstrate an essential role for regulatory T cells in maintaining age retinal homeostasis and preventing age-related neurodegeneration. This previously undescribed role of regulatory T cells in limiting retinal inflammation, RPE/choroid epithelium damage and subsequently photoreceptor loss with age, opens novel avenues to explore regulatory T cell neuroprotective and anti-inflammatory properties as potential therapeutic approaches for age-related retinal diseases., This work was supported by the Wellcome (110138/Z/15/Z to DCF), ECTRIMS postdoctoral fellowship (to AGF), Wellcome Trust ISSF fellowship through QUB (to AGF), Miguel Servet Fellowship from the Spanish Institute of Health Carlos III (CP21/00032 to AGF), The Leverhulme Trust (ECF-2014–390, to YD), the Maria Zambrano fellowship from Spanish Ministry of Science, Innovation and Universities, financed by European Union “NextGenerationEU” (Universitat Autònoma de Barcelona, to MLS), and H2020 RECOGNISED, European Commission and Fight for Sight UK Grant Agreement N° 847749 (to AS)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Testing the use of retinal microvascular parameters to identify individuals with type 2 diabetes with mild cognitive impairment

  • Pedersen, Frederik
  • Lois, Noemi
  • Biessels, Geert Jan
  • Exalto, Lieza
  • Pérez-Hoyos, Santiago
  • Simó Canonge, Rafael
Cognitive dysfunction; Color fundus photography; Diabetic retinopathy, Disfunción cognitiva; Fotografía del fondo de ojo en color; Retinopatía diabética, Disfunció cognitiva; Fotografia del fons d'ull en color; Retinopatia diabètica, Objective To investigate the use of retinal microvascular parameters, as determined by color fundus photographs (CFP), to detect individuals with type 2 diabetes with mild cognitive impairment (MCI). Methods The current study is based on cross sectional data obtained prospectively in RECOGNISED, a European Union-funded multicenter observational study involving individuals 65 years of age or older with type 2 diabetes. The diagnosis of MCI was established based on cognitive screening, followed by a detailed neuropsychological test battery. CFP were analyzed to quantify retinal vessel width, arteriovenous ratio, tortuosity, and fractal dimension. Crude and multivariable logistic regression models were used to investigate the association between MCI and retinal microvascular parameters and the ability of the latter to identify individuals with MCI using both eyes in our analysis if eligible. Results We included 578 eyes of 307 individuals with type 2 diabetes of whom 182 had MCI and 125 had normal cognition. Median age was 72 (IQR 69–77) years, 65 % were male, and median diabetes duration was 19 (IQR 12–24) years. We found arteriolar tortuosity was associated with MCI in the multivariable analysis (OR 1.44 [95 % CI 1.08–1.92]; the less the tortuosity the higher the risk). When estimating the discriminative ability of the retinal microvascular parameters, we found an AUC of 0.73. Conclusion In people with type 2 diabetes, a lower retinal arteriolar tortuosity was associated with MCI. In addition, we found retinal microvascular parameters to have an acceptable discrimination ability when paired with patient’s characteristics., European Union’s Horizon 2020 research and innovation programme under grant agreement No. 847749.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes

  • Vargas‑Soria, Maria
  • Ramos-Rodriguez, Juan Jose
  • Hierro‑Bujalance, Carmen
  • Carranza‑Naval, María José
  • Calvo‑Rodriguez, Maria
  • Simó Canonge, Rafael
  • del Marco, Angel
Amyloid; Multiphoton microscopy; Prediabetes, Amiloide; Microscòpia multifotònica; Prediabetis, Amiloide; Microscopía multifotónica; Prediabetes, Background While aging is the main risk factor for Alzheimer´s disease (AD), emerging evidence suggests that metabolic alterations such as type 2 diabetes (T2D) are also major contributors. Indeed, several studies have described a close relationship between AD and T2D with clinical evidence showing that both diseases coexist. A hallmark pathological event in AD is amyloid-β (Aβ) deposition in the brain as either amyloid plaques or around leptomeningeal and cortical arterioles, thus constituting cerebral amyloid angiopathy (CAA). CAA is observed in 85–95% of autopsy cases with AD and it contributes to AD pathology by limiting perivascular drainage of Aβ. Methods To further explore these alterations when AD and T2D coexist, we have used in vivo multiphoton microscopy to analyze over time the Aβ deposition in the form of plaques and CAA in a relevant model of AD (APPswe/PS1dE9) combined with T2D (db/db). We have simultaneously assessed the effects of high-fat diet-induced prediabetes in AD mice. Since both plaques and CAA are implicated in oxidative-stress mediated vascular damage in the brain, as well as in the activation of matrix metalloproteinases (MMP), we have also analyzed oxidative stress by Amplex Red oxidation, MMP activity by DQ™ Gelatin, and vascular functionality. Results We found that prediabetes accelerates amyloid plaque and CAA deposition, suggesting that initial metabolic alterations may directly affect AD pathology. T2D significantly affects vascular pathology and CAA deposition, which is increased in AD-T2D mice, suggesting that T2D favors vascular accumulation of Aβ. Moreover, T2D synergistically contributes to increase CAA mediated oxidative stress and MMP activation, affecting red blood cell velocity. Conclusions Our data support the cross-talk between metabolic disease and Aβ deposition that affects vascular integrity, ultimately contributing to AD pathology and related functional changes in the brain microvasculature., University of Cadiz Predoctoral Fellowship (CHB). This study is part of the current project (RECOGNISED; Clinical Trials gov registration no. NCT04281186) funded by the European Commission (H2020 programme-GA 847749) focusing on common mechanisms in the pathogenesis of diabetic retinopathy, brain pathology and cognitive impairment, with special interest in the neurovascular unit, in the T2D population. Agencia Estatal de Investigacion. Ministerio de Ciencia e Innovacion. Programa Estatal de Generacion de Conocimiento y Fortalecimiento Cientifico y Tecnologico del Sistema de I + D + i y del Programa Estatal de I + D + i Orientada a los Retos de la Sociedad, del Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion (PID2020-115499RB-I00/AEI/10.130 39/501100011033). Programa Estatal de I + D + I orientada a los Retos de la Sociedad (BFU 2016-75038-R), financed by the Agencia Estatal de Investigacion (AEI) and the Fondo Europeo de Desarrollo Regional (FEDER), Ministerio de Economia y Competitividad. Proyectos de I + D + i, en regimen de concurrencia competitiva, destinadas a las universidades y entidades publicas de investigacion calificadas como agentes del Sistema Andaluz del Conocimiento, en el ambito del Plan Andaluz de Investigacion, Desarrollo e Innovación (PAIDI 2020). Andalucia se mueve con Europa (P20-00928).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Association between retinal microvasculature and cerebral small vessel function in type 2 diabetes: An ultrahigh field MRI study

  • de leijer, jan
  • Pham, Stanley D. T.
  • Vissers, Tessa A. C. M.
  • Exalto, Lieza G.
  • Schlingemann, Reinier O.
  • Siero, Jeroen
  • Simó Canonge, Rafael
Complicaciones de la diabetes; Enfermedad de larga duración; Diabetes tipo 2, Retinal microvasculature; Diabetes complications; Type 2 diabetes, Malaltia de petits vasos cerebrals; Complicacions de la diabetis; Diabetis tipus 2, This study is a substudy of RECOGNISED, funded by the European Commission's Horizon 2020 Work Programme 2018–2020 (grant agreement no: 847749).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer's disease and type two diabetes

  • Vargas-Soria, Maria
  • Ramos-Rodriguez, Juan Jose
  • Del Marco, Angel|||0000-0001-7911-2395
  • Hierro-Bujalance, Carmen
  • Carranza-Naval, Maria Jose
  • Calvo-Rodriguez, Maria
  • van Veluw, Susanne J.
  • Stitt, Alan W.|||0000-0002-8647-9918
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Bacskai, Brian J.
  • Infante-Garcia, Carmen
  • Garcia-Alloza, Monica|||0000-0003-1610-4114
While aging is the main risk factor for Alzheimer's disease (AD), emerging evidence suggests that metabolic alterations such as type 2 diabetes (T2D) are also major contributors. Indeed, several studies have described a close relationship between AD and T2D with clinical evidence showing that both diseases coexist. A hallmark pathological event in AD is amyloid-β (Aβ) deposition in the brain as either amyloid plaques or around leptomeningeal and cortical arterioles, thus constituting cerebral amyloid angiopathy (CAA). CAA is observed in 85-95% of autopsy cases with AD and it contributes to AD pathology by limiting perivascular drainage of Aβ. To further explore these alterations when AD and T2D coexist, we have used in vivo multiphoton microscopy to analyze over time the Aβ deposition in the form of plaques and CAA in a relevant model of AD (APPswe/PS1dE9) combined with T2D (db/db). We have simultaneously assessed the effects of high-fat diet-induced prediabetes in AD mice. Since both plaques and CAA are implicated in oxidative-stress mediated vascular damage in the brain, as well as in the activation of matrix metalloproteinases (MMP), we have also analyzed oxidative stress by Amplex Red oxidation, MMP activity by DQ ™ Gelatin, and vascular functionality. We found that prediabetes accelerates amyloid plaque and CAA deposition, suggesting that initial metabolic alterations may directly affect AD pathology. T2D significantly affects vascular pathology and CAA deposition, which is increased in AD-T2D mice, suggesting that T2D favors vascular accumulation of Aβ. Moreover, T2D synergistically contributes to increase CAA mediated oxidative stress and MMP activation, affecting red blood cell velocity. Our data support the cross-talk between metabolic disease and Aβ deposition that affects vascular integrity, ultimately contributing to AD pathology and related functional changes in the brain microvasculature.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Testing the use of retinal microvascular parameters to identify individuals with type 2 diabetes with mild cognitive impairment

  • Pedersen, Frederik
  • Lois, Noemi
  • Biessels, Geert Jan
  • Exalto, Lieza
  • Pérez-Hoyos, Santiago
  • Simó Canonge, Rafael
Cognitive dysfunction; Color fundus photography; Diabetic retinopathy, Disfunción cognitiva; Fotografía del fondo de ojo en color; Retinopatía diabética, Disfunció cognitiva; Fotografia del fons d'ull en color; Retinopatia diabètica, Objective To investigate the use of retinal microvascular parameters, as determined by color fundus photographs (CFP), to detect individuals with type 2 diabetes with mild cognitive impairment (MCI). Methods The current study is based on cross sectional data obtained prospectively in RECOGNISED, a European Union-funded multicenter observational study involving individuals 65 years of age or older with type 2 diabetes. The diagnosis of MCI was established based on cognitive screening, followed by a detailed neuropsychological test battery. CFP were analyzed to quantify retinal vessel width, arteriovenous ratio, tortuosity, and fractal dimension. Crude and multivariable logistic regression models were used to investigate the association between MCI and retinal microvascular parameters and the ability of the latter to identify individuals with MCI using both eyes in our analysis if eligible. Results We included 578 eyes of 307 individuals with type 2 diabetes of whom 182 had MCI and 125 had normal cognition. Median age was 72 (IQR 69–77) years, 65 % were male, and median diabetes duration was 19 (IQR 12–24) years. We found arteriolar tortuosity was associated with MCI in the multivariable analysis (OR 1.44 [95 % CI 1.08–1.92]; the less the tortuosity the higher the risk). When estimating the discriminative ability of the retinal microvascular parameters, we found an AUC of 0.73. Conclusion In people with type 2 diabetes, a lower retinal arteriolar tortuosity was associated with MCI. In addition, we found retinal microvascular parameters to have an acceptable discrimination ability when paired with patient’s characteristics., European Union’s Horizon 2020 research and innovation programme under grant agreement No. 847749.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes

  • Vargas‑Soria, Maria
  • Ramos-Rodriguez, Juan Jose
  • Hierro‑Bujalance, Carmen
  • Carranza‑Naval, María José
  • Calvo‑Rodriguez, Maria
  • Simó Canonge, Rafael
  • del Marco, Angel
Amyloid; Multiphoton microscopy; Prediabetes, Amiloide; Microscòpia multifotònica; Prediabetis, Amiloide; Microscopía multifotónica; Prediabetes, Background While aging is the main risk factor for Alzheimer´s disease (AD), emerging evidence suggests that metabolic alterations such as type 2 diabetes (T2D) are also major contributors. Indeed, several studies have described a close relationship between AD and T2D with clinical evidence showing that both diseases coexist. A hallmark pathological event in AD is amyloid-β (Aβ) deposition in the brain as either amyloid plaques or around leptomeningeal and cortical arterioles, thus constituting cerebral amyloid angiopathy (CAA). CAA is observed in 85–95% of autopsy cases with AD and it contributes to AD pathology by limiting perivascular drainage of Aβ. Methods To further explore these alterations when AD and T2D coexist, we have used in vivo multiphoton microscopy to analyze over time the Aβ deposition in the form of plaques and CAA in a relevant model of AD (APPswe/PS1dE9) combined with T2D (db/db). We have simultaneously assessed the effects of high-fat diet-induced prediabetes in AD mice. Since both plaques and CAA are implicated in oxidative-stress mediated vascular damage in the brain, as well as in the activation of matrix metalloproteinases (MMP), we have also analyzed oxidative stress by Amplex Red oxidation, MMP activity by DQ™ Gelatin, and vascular functionality. Results We found that prediabetes accelerates amyloid plaque and CAA deposition, suggesting that initial metabolic alterations may directly affect AD pathology. T2D significantly affects vascular pathology and CAA deposition, which is increased in AD-T2D mice, suggesting that T2D favors vascular accumulation of Aβ. Moreover, T2D synergistically contributes to increase CAA mediated oxidative stress and MMP activation, affecting red blood cell velocity. Conclusions Our data support the cross-talk between metabolic disease and Aβ deposition that affects vascular integrity, ultimately contributing to AD pathology and related functional changes in the brain microvasculature., University of Cadiz Predoctoral Fellowship (CHB). This study is part of the current project (RECOGNISED; Clinical Trials gov registration no. NCT04281186) funded by the European Commission (H2020 programme-GA 847749) focusing on common mechanisms in the pathogenesis of diabetic retinopathy, brain pathology and cognitive impairment, with special interest in the neurovascular unit, in the T2D population. Agencia Estatal de Investigacion. Ministerio de Ciencia e Innovacion. Programa Estatal de Generacion de Conocimiento y Fortalecimiento Cientifico y Tecnologico del Sistema de I + D + i y del Programa Estatal de I + D + i Orientada a los Retos de la Sociedad, del Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion (PID2020-115499RB-I00/AEI/10.130 39/501100011033). Programa Estatal de I + D + I orientada a los Retos de la Sociedad (BFU 2016-75038-R), financed by the Agencia Estatal de Investigacion (AEI) and the Fondo Europeo de Desarrollo Regional (FEDER), Ministerio de Economia y Competitividad. Proyectos de I + D + i, en regimen de concurrencia competitiva, destinadas a las universidades y entidades publicas de investigacion calificadas como agentes del Sistema Andaluz del Conocimiento, en el ambito del Plan Andaluz de Investigacion, Desarrollo e Innovación (PAIDI 2020). Andalucia se mueve con Europa (P20-00928).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Association between retinal microvasculature and cerebral small vessel function in type 2 diabetes: An ultrahigh field MRI study

  • de leijer, jan
  • Pham, Stanley D. T.
  • Vissers, Tessa A. C. M.
  • Exalto, Lieza G.
  • Schlingemann, Reinier O.
  • Siero, Jeroen
  • Simó Canonge, Rafael
Complicaciones de la diabetes; Enfermedad de larga duración; Diabetes tipo 2, Retinal microvasculature; Diabetes complications; Type 2 diabetes, Malaltia de petits vasos cerebrals; Complicacions de la diabetis; Diabetis tipus 2, This study is a substudy of RECOGNISED, funded by the European Commission's Horizon 2020 Work Programme 2018–2020 (grant agreement no: 847749).
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Tesis doctoral (DoctoralThesis)

Complicaciones centrales en modelos de enfermedad de alzheimer y diabetes: papel de la empagliflozina

  • Hierro Bujalance, Carmen
La enfermedad de Alzheimer (EA) es la causa más común de demencia. Además de las características neuropatológicas clásicas, otras complicaciones, como el proceso neuroinflamatorio, también han cobrado relevancia en los últimos años. Sin embargo, la valoración in vivo de la inflamación y la microglía resulta especialmente difícil. La microscopía multifotón (MMF) permite, con alta resolución, la detección in vivo de células de microglía individuales en el cerebro de modelos complejos de forma crónica. En este trabajo hemos realizado una revisión de estudios que emplean la MMF en ratones modelo de EA. Mediante MMF es posible evaluar el papel dual de la microglía en la EA: favoreciendo el aclaramiento de amiloide en estadios iniciales y contribuyendo a su depósito cuando el proceso se hace crónico. Otros trabajos de MMF han revelado que la inmunoterapia con anticuerpos anti β-amiloide (βA), como enfoque terapéutico clave para el tratamiento de la EA, contribuye a la eliminación de βA mediante la activación de microglía. En conjunto los estudios basados en MMF pueden ayudar a esclarecer el papel de la microglía en el proceso inflamatorio y los cambios que se producen a nivel central a medida que progresa la EA. Además del proceso neuroinflamatorio, el concepto de neurodegeneración también se ha ampliado para incluir otras alteraciones menos clásicas asociadas a la EA, como las alteraciones en la proliferación y neurogenesis. Dada la relación entre la EA y las enfermedades metabólicas, y en concreto la diabetes mellitus tipo 2 (DM2), hemos analizado los procesos de proliferación celular y neurogénesis mediante doble inmunotinción con 5´-bromo-2´-desoxiuridina (BrdU) y doblecortina (DCX) en tres modelos diferentes de EA y alteraciones metabólicas. Hemos utilizado un modelo de EA tratado con streptozotozina (STZ) para inducir diabetes mellitus tipo 1 (DM1) (ratón APP/PS1-STZ), un modelo de EA y prediabetes inducido por el tratamiento a largo plazo con una dieta rica en grasas (DRG) (ratón APP/PS1-DRG) y un modelo mixto de EA-DM2 (ratón APP/PS1xdb/db). Observamos una reducción general en la proliferación celular y neurogénesis tras la administración de STZ en la zona subventricular (ZSV), corteza e hipocampo. Mientras, en los ratones APP/PS1-DRG observamos un incremento de este proceso en la corteza. Finalmente, detectamos un aumento de la proliferación celular y la neurogénesis en la ZSV y giro dentado de los ratones APP/PS1xdb/db a las 14 y 26 semanas de edad, acompañado de un ligero aumento en la proliferación en la corteza. Aunque estudios recientes han mostrado la expresión de DCX en células T-CD8+ y molécula ionizada adaptadora de unión a calcio 1 (Iba1+) en la proximidad de las placas seniles (PS), en nuestro estudio apenas observamos células DCX+/CD8+ y no detectamos ninguna célula DCX+/Iba1+. También observamos que los parámetros metabólicos, como el peso corporal y los niveles de glucosa, son buenos predictores de las alteraciones en los niveles de βA cortical y del hipocampo. Es más, los parámetros metabólicos también se correlacionan con la proliferación celular y neurogénesis en los ratones APP/PS1xdb/db. Nuestros resultados apoyan que las alteraciones metabólicas, características de la DM2, pueden predecir las complicaciones cerebrales propias de la EA a la par que se produce una exacerbación de la patología cuando ambas enfermedades se establecen concomitantemente. A la complejidad y a su relación con la DM2, debe sumarse el hecho de que la EA a día de hoy no tiene tratamiento exitoso. Esto hace necesaria la búsqueda de alternativas terapéuticas. La relación EA-DM2 apoya el estudio de fármacos antidiabéticos en la patología tipo Alzheimer. La empagliflozina (EMP) es un inhibidor del transportador sodio-glucosa 2 (iSGLT2) recientemente comercializado, capaz de controlar la patología metabólica y de reducir las muertes de causa cardiovascular asociadas a la DM2. Teniendo en cuenta estas consideraciones, hemos tratado el modelo mixto de EA-DM2 (ratón APP/PS1xdb/db) con EMP durante 22 semanas. Nuestros resultados muestran como la EMP ayuda a mantener los niveles de insulina en los ratones diabéticos. A nivel central, limita el adelgazamiento cortical y la pérdida neuronal, reduciendo la atrofia cerebral. La carga de hemorragias y de microglía también disminuye tras el tratamiento con EMP, mejorando la patología de pequeño vaso y limitando la inflamación. De igual modo, la carga de PS y la fosforilación de tau se reducen, mejorando la patología Alzheimer. Todo esto se acompaña de una mejora de los déficits cognitivos que presentan los ratones APP/PS1xdb/db. En conjunto, nuestros resultados apoyan el posible papel de la EMP en la patología asociada a la EA. La situación crítica de los pacientes de Alzheimer hace necesario su abordaje desde diferentes ángulos. En los últimos años han cobrado relevancia características de la enfermedad, como alteraciones del proceso inflamatorio central, y los estudios con MMF pueden ayudar a esclarecer el papel fisiológico y patológico del proceso neuroinflamatorio y la microglía en el cerebro de EA. Otras alteraciones, como los procesos de proliferación y neurogénesis, también se ven afectados en la EA y en modelos mixtos de EA-DM. La exacerbación de la patología central en nuestro modelo mixto (APP/PS1xdb/db) subraya la estrecha relación entre ambas enfermedades y un posible efecto sinérgico. Teniendo en cuenta este agravamiento generalizado cuando ambas patologías coexisten, y la estrecha relación EA-DM, es posible que el tratamiento con fármacos antidiabéticos pueda limitar los daños a nivel central. Así la administración de EMP mejora la patología tipo Alzheimer, inflamatoria y vascular en los animales APP/PS1xdb/db, abriendo la puerta a continuar estos estudios.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Disruption of cortical cell type composition and function underlies diabetes-associated cognitive decline

  • Little, K.
  • Marco Delgado, Ángel José del
  • Llorián-Salvador, M.
  • Vargas Soria, María
  • Turch-Anguera, M.
  • Solé, M.
  • Bakker, N.
  • Scullion, S.
  • Comella, J.X.
  • Klaassen, I.
  • Simó, R.
  • García Alloza, Mónica
  • Tiwari, V.K.
  • Stitt, A.W.
Aims/hypothesis Type 2 diabetes is associated with increased risk of cognitive decline although the pathogenic basis for this remains obscure. Deciphering diabetes-linked molecular mechanisms in cells of the cerebral cortex could uncover novel therapeutic targets. Methods Single-cell transcriptomic sequencing (scRNA-seq) was conducted on the cerebral cortex in a mouse model of type 2 diabetes (db/db mice) and in non-diabetic control mice in order to identify gene expression changes in distinct cell subpopulations and alterations in cell type composition. Immunohistochemistry and metabolic assessment were used to validate the fndings from scRNA-seq and to investigate whether these cell-specifc dysfunctions impact the neurovascular unit (NVU). Furthermore, the behavioural and cognitive alterations related to these dysfunctions in db/db mice were assessed via Morris water maze and novel object discrimination tests. Finally, results were validated in post-mortem sections and protein isolates from individuals with type 2 diabetes. Results Compared with non-diabetic control mice, the db/db mice demonstrated disrupted brain function as revealed by losses in episodic and spatial memory and this occurred concomitantly with dysfunctional NVU, neuronal circuitry and cerebral atrophy. scRNA-seq of db/db mouse cerebral cortex revealed cell population changes in neurons, glia and microglia linked to functional regulatory disruption including neuronal maturation and altered metabolism. These changes were validated through immunohistochemistry and protein expression analysis not just in the db/db mouse cerebral cortex but also in postmortem sections and protein isolates from individuals with type 2 diabetes (74.3 ± 5.5 years) compared with non-diabetic control individuals (87.0 ± 8.5 years). Furthermore, metabolic and synaptic gene disruptions were evident in cortical NVU cell populations and associated with a decrease in vascular density.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes

  • Vargas Soria, María
  • Ramos-Rodríguez, Juan José
  • Marco Delgado, Ángel José del
  • Hierro Bujalance, Carmen
  • Carranza Naval, María José
  • Calvo-Rodriguez, Maria
  • van Veluw, Susanne J.
  • Stitt, Alan W.
  • Simó, Rafael
  • Bacskai, Brian J.
  • Infante-Garcia, Carmen
  • García Alloza, Mónica
Background While aging is the main risk factor for Alzheimer ' s disease (AD), emerging evidence suggests that metabolic alterations such as type 2 diabetes (T2D) are also major contributors. Indeed, several studies have described a close relationship between AD and T2D with clinical evidence showing that both diseases coexist. A hallmark pathological event in AD is amyloid-beta (A beta) deposition in the brain as either amyloid plaques or around leptomeningeal and cortical arterioles, thus constituting cerebral amyloid angiopathy (CAA). CAA is observed in 85-95% of autopsy cases with AD and it contributes to AD pathology by limiting perivascular drainage of A beta. Methods To further explore these alterations when AD and T2D coexist, we have used in vivo multiphoton microscopy to analyze over time the A beta deposition in the form of plaques and CAA in a relevant model of AD (APPswe/PS1dE9) combined with T2D (db/db). We have simultaneously assessed the effects of high-fat diet-induced prediabetes in AD mice. Since both plaques and CAA are implicated in oxidative-stress mediated vascular damage in the brain, as well as in the activation of matrix metalloproteinases (MMP), we have also analyzed oxidative stress by Amplex Red oxidation, MMP activity by DQ((TM)) Gelatin, and vascular functionality. Results We found that prediabetes accelerates amyloid plaque and CAA deposition, suggesting that initial metabolic alterations may directly affect AD pathology. T2D significantly affects vascular pathology and CAA deposition, which is increased in AD-T2D mice, suggesting that T2D favors vascular accumulation of A beta. Moreover, T2D synergistically contributes to increase CAA mediated oxidative stress and MMP activation, affecting red blood cell velocity. Conclusions Our data support the cross-talk between metabolic disease and A beta deposition that affects vascular integrity, ultimately contributing to AD pathology and related functional changes in the brain microvasculature.